sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 4-(4-methylcyclohexyl)-4-oxobutanoic acid

4-(4-methylcyclohexyl)-4-oxobutanoic acid

CAS No.:
220203-23-6
Catalog Number:
AG01C3YC
Molecular Formula:
C11H18O3
Molecular Weight:
198.2588
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG01C3YC
Chemical Name:
4-(4-methylcyclohexyl)-4-oxobutanoic acid
CAS Number:
220203-23-6
Molecular Formula:
C11H18O3
Molecular Weight:
198.2588
MDL Number:
MFCD21296520
IUPAC Name:
4-(4-methylcyclohexyl)-4-oxobutanoic acid
InChI:
InChI=1S/C11H18O3/c1-8-2-4-9(5-3-8)10(12)6-7-11(13)14/h8-9H,2-7H2,1H3,(H,13,14)
InChI Key:
JOWMTYWOBJALGB-UHFFFAOYSA-N
SMILES:
CC1CCC(CC1)C(=O)CCC(=O)O
UNII:
U419K07BFP
Properties
Complexity:
215  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
198.126g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
198.262g/mol
Monoisotopic Mass:
198.126g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
54.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.7  
Literature
Title Journal
Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats. Diabetes, obesity & metabolism 20050901
Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats. European journal of pharmacology 20030822
A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism. The Journal of pharmacology and experimental therapeutics 20010601
A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide. The Journal of pharmacology and experimental therapeutics 20010101
Properties